The Health and Social Care Committee will be holding an evidence session in October on the impact of a no-deal Brexit on health and social care.
The session will be an opportunity for the Committee to follow up its earlier reports, Brexit and health and social care: people and process and Brexit: medicines, medical devices and substances of human origin.
Ahead of the session, the Committee is inviting written submissions from all interested parties, setting out:
- What the impact of a no-deal Brexit* is likely to be on their sector of the health and social care system (whether that be patients, suppliers to the health and social care system, providers of NHS or social care services, NHS or social care staff, or others).
- Specifically, what the risks are to patients and to the health and social care system of leaving the European Union without a withdrawal agreement. The Committee would be particularly pleased to hear from patient representative groups about the extent of the potential risk to patient care of any disruption to the supply from the EU-27 to the UK of medicines, medical devices or substances of human origin.
- How effectively stakeholders are planning for the possibility of a no-deal Brexit.
- How effectively they consider the Government is planning for such an outcome.
- What further planning, or reassurances, are required in order to ensure that the impact of a no-deal Brexit on health and social care would be minimised.
The session only appears to want comments on any of those points which apply to you or the organisation you represent.
You must send your submission by Monday 15 October.
The date of the oral evidence, and the witnesses to be heard, will be announced later.